SKN | Electra Therapeutics Prices $350 Million IPO as Biotech Enters Nasdaq Market
Electra Therapeutics, Inc. has priced its initial public offering at $15 per share, raising approximately $350 million in gross proceeds after increasing the size...
SKN | Leader’s Advantage Acquisition Corp. Launches $150 Million Nasdaq SPAC IPO
Leader’s Advantage Acquisition Corp. has priced its initial public offering at $10 per unit, targeting $150 million in gross proceeds as it prepares to...
SKN | Livestreaming Platform C2 Capital Group Withdraws $17 Million IPO
C2 Capital Group, which operates a livestreaming platform with built-in gifting tools, has withdrawn its plans for an initial public offering in the United...
SKN | Haymaker Acquisition V Prices $250 Million IPO to Target Industrial and Consumer Businesses
Key Points:
Haymaker Acquisition V raised $250 million by offering 25 million units at $10 each, marking the fifth Haymaker blank check company targeting...
SKN | AbCellera Biologics Shares Surge 11.48% as Antibody-Based Drug Pipeline Remains in Focus
AbCellera Biologics Inc. (Nasdaq: ABCL) shares rose 11.48% to $13.01 in the market update shown, with the biotechnology company continuing to develop antibody-based medicines...